Effect of β-Blockers and Other Antihypertensive Drugs On the Risk of Melanoma Recurrence and Death

The results confirm and strengthen previous findings that β-blocker use is associated with a reduced risk of melanoma recurrence and death. The results also indicate the strong need for a randomized clinical trial to conclusively assess whether β-blockers afford protection against melanoma recurrence and death.